John Sweetenham, senior director of clinical affairs and executive medical director of Huntsman Cancer Institute at The University of Utah, in a recent write up takes a look at some of the potential benefits real-world evidence (RWE) has to offer in oncology, as well as some of the possible […]
Article: Value-Based Oncology Care Fails to Address Psychosocial Needs of Patients
A recent article published on Oncology Nursing News suggests conversations about value-based oncology care are ultimately ignoring individual patients, though a growing belief that patient-centric care and shared decision-making are indispensable components in health care delivery. "Part of the […]
Study Finds Success in Value-Based Oncology Model Dependent Upon Type of Cancer Treated
A recent study by Avalere found that an oncology practice's ability to survive in the Oncology Care Model (OCM) can be dependent upon the types of cancers being treated by the practice. According to a Managed Healthcare Executive (MHE) report, the research analyzed care costs and OCM […]
Welch Resigns Amid Plagiarism Dispute
Gilbert Welch, a top health care policy scholar in the U.S., has stepped down from his position at Dartmouth College following an investigation into plagiarism allegations, STAT reports. Dartmouth, according to the report, conducted an internal investigation into the claims that Welch plagiarized […]
Study: Payers Could Save by Cutting Unwarranted Components of Cancer Care
A recent white paper sponsored by NantHealth looks at a recent study which suggests unwarranted components of cancer care racked up an average $25,579 per patient. The multi-year study was conducted in association with researchers from Abramson Cancer Center of the University of Pennsylvania and […]
Neuss: Progress Being Made in Higher-Value Cancer Care
Dr. Michael Neuss with the Vanderbilt-Ingram Cancer Center said during the National Comprehensive Cancer Network's annual meeting in Florida that some progress had been made toward creating more value in cancer care delivery, according to a Journal of Clinical Pathways report. Despite that […]
Study: Physicians Don’t Always See Financial Burden of Cancer
A recent study published in the journal Cancer found health care providers are failing to address the "financial devastation" that often comes with cancer care, according to a Reuters report. "We are seeing in our survey data, especially among vulnerable populations such as ethnic and racial […]
Are Biosimilars the Key to Boosting Access, Controlling Prices in Oncology?
Cost-saving agents like biosimilars, compounded with more cost-efficient drug development strategies, could be the key to developing a more sustainable field of oncology, NYU Langone's Perlmutter Cancer Center Associate Professor Yelena Novik says. Novik tells OncLive that the issue is a "complex" […]
ICER Releases Draft Evidence Report on Antiandrogen Therapies
The Institute for Clinical and Economic Review announced a Draft Evidence Report focused on the comparative clinical effectiveness of three antiandrogen therapies for prostate cancer. The report analyzes abiraterone acetate, apalutamide and enzalutamide, as well as the value of enzalutamide and […]
AMCP Learn Offers Best of Annual 2018 Nexus Meeting
The Academy of Managed Care Pharmacy is offering ten top-rated sessions of its 2018 Nexus meeting on AMCP Learn. The offering is available until April 25, 2021, according to AMCP's website. AMCP is offering in the set home study activities, including:AMCP Headline Session: 2017–2018 […]
